how much of what we believe about A1c actually comes from glycaemic control threads
Trying to get a straight answer on this: how much of what we believe about A1c actually comes from glycaemic control threads.
Brought the whole CGM export to my appointment rather than one number. Entirely different conversation.
Panicked over a first-day sensor reading and rebuilt my week around it. It was the sensor.
Time in range told me far more than the average did. Two quarters with the same A1c looked completely different on the sensor.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Sensor accuracy varies across wear, and readings on the first day are the least reliable. Calibration practice and compression artefacts explain many alarming single values.
Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board.
Sensor accuracy varies across wear, and readings on the first day are the least reliable.
This is the distinction that resolves most of the confusion here — average versus shape.
Incretin-based agents stimulate insulin secretion in a glucose-dependent manner, which is why hypoglycaemia risk with them alone is low. Risk rises with agents that act independently of glycaemia.
My A1c moved and it turned out to have nothing to do with glucose at all.